Watch Ticker

Blueprint Medicines Corporation

Go to Blueprint Medicines Corporation Website

$129.46

(%)

Live

Previous Close

$129.46

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Sanofi Press Release - Press Release: Sanofi completes acquisition of Blueprint Medicines

Sanofi has completed its acquisition of Blueprint Medicines for $129 per share, adding a rare immunology medicine (Ayvakit/Ayvakyt) and promising pipeline focused on systemic mastocytosis to its portfolio.

Related tickers: SNY, BPMC.

Read Full Article

Sanofi Press Release - Communiqué de presse : Sanofi finalise l’acquisition de Blueprint Medicines

Sanofi completed the acquisition of Blueprint Medicines on July 18, 2025, adding specialized immunological rare disease treatments and medications targeting mastocytosis to its portfolio for $129 per share.

Related tickers: SNY, BPMC.

Read Full Article

Trending Tickers

Please sign in to view